scholarly journals Highly Pathogenic Avian Influenza A/H5N1 – update and overview of 2006

2006 ◽  
Vol 11 (51) ◽  
Author(s):  
Collective Influenza team (ECDC)

As of 29 November 2006, 258 human H5N1 infections that meet its strict laboratory criteria have been reported to the World Health Organization (WHO) since reporting began for 2003

2004 ◽  
Vol 8 (6) ◽  
Author(s):  

The Ministry of Health in Vietnam and the World Health Organization (WHO) have confirmed three new cases of highly pathogenic avian influenza (HPAI) A H5N1 in humans.


2004 ◽  
Vol 8 (29) ◽  
Author(s):  

Two press releases from the World Health Organization (WHO) last week have refocused international attention on highly pathogenic avian influenza (HPAI) A(H5N1)


2004 ◽  
Vol 8 (40) ◽  
Author(s):  

Two new human cases of avian influenza A(H5N1) infection in Thailand have been confirmed by the World Health Organization. The two cases were in a 26 year old woman who has died, and her 32 year old sister who has been admitted to hospital. They are part of a family cluster being investigated to determine whether human-to-human transmission has occurred.


BMC Medicine ◽  
2020 ◽  
Vol 18 (1) ◽  
Author(s):  
Xinhua Chen ◽  
Wei Wang ◽  
Yan Wang ◽  
Shengjie Lai ◽  
Juan Yang ◽  
...  

Abstract Background Highly pathogenic avian influenza A(H5N1) virus poses a global public health threat given severe and fatal zoonotic infections since 1997 and ongoing A(H5N1) virus circulation among poultry in several countries. A comprehensive assessment of the seroprevalence of A(H5N1) virus antibodies remains a gap and limits understanding of the true risk of A(H5N1) virus infection. Methods We conducted a systematic review and meta-analysis of published serosurveys to assess the risk of subclinical and clinically mild A(H5N1) virus infections. We assessed A(H5N1) virus antibody titers and changes in titers among populations with variable exposures to different A(H5N1) viruses. Results Across studies using the World Health Organization-recommended seropositive definition, the point estimates of the seroprevalence of A(H5N1) virus-specific antibodies were higher in poultry-exposed populations (range 0–0.6%) and persons exposed to both human A(H5N1) cases and infected birds (range 0.4–1.8%) than in close contacts of A(H5N1) cases or the general population (none to very low frequencies). Seroprevalence was higher in persons exposed to A(H5N1) clade 0 virus (1.9%, range 0.7–3.2%) than in participants exposed to other clades of A(H5N1) virus (range 0–0.5%) (p < 0.05). Seroprevalence was higher in poultry-exposed populations (range 0–1.9%) if such studies utilized antigenically similar A(H5N1) virus antigens in assays to A(H5N1) viruses circulating among poultry. Conclusions These low seroprevalences suggest that subclinical and clinically mild human A(H5N1) virus infections are uncommon. Standardized serological survey and laboratory methods are needed to fully understand the extent and risk of human A(H5N1) virus infections.


2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Knut Madslien ◽  
Torfinn Moldal ◽  
Britt Gjerset ◽  
Sveinn Gudmundsson ◽  
Arne Follestad ◽  
...  

Abstract Background Several outbreaks of highly pathogenic avian influenza (HPAI) caused by influenza A virus of subtype H5N8 have been reported in wild birds and poultry in Europe during autumn 2020. Norway is one of the few countries in Europe that had not previously detected HPAI virus, despite widespread active monitoring of both domestic and wild birds since 2005. Results We report detection of HPAI virus subtype H5N8 in a wild pink-footed goose (Anser brachyrhynchus), and several other geese, ducks and a gull, from south-western Norway in November and December 2020. Despite previous reports of low pathogenic avian influenza (LPAI), this constitutes the first detections of HPAI in Norway. Conclusions The mode of introduction is unclear, but a northward migration of infected geese or gulls from Denmark or the Netherlands during the autumn of 2020 is currently our main hypothesis for the introduction of HPAI to Norway. The presence of HPAI in wild birds constitutes a new, and ongoing, threat to the Norwegian poultry industry, and compliance with the improved biosecurity measures on poultry farms should therefore be ensured. [MK1]Finally, although HPAI of subtype H5N8 has been reported to have very low zoonotic potential, this is a reminder that HPAI with greater zoonotic potential in wild birds may pose a threat in the future. [MK1]Updated with a sentence emphasizing the risk HPAI pose to poultry farms, both in the Abstract and in the Conclusion-section in main text, as suggested by Reviewer 1 (#7).


2015 ◽  
Vol 64 (1) ◽  
pp. 144-156 ◽  
Author(s):  
N. Haider ◽  
K. Sturm-Ramirez ◽  
S. U. Khan ◽  
M. Z. Rahman ◽  
S. Sarkar ◽  
...  

2015 ◽  
Vol 21 (5) ◽  
pp. 775-780 ◽  
Author(s):  
Hye-Ryoung Kim ◽  
Yong-Kuk Kwon ◽  
Il Jang ◽  
Youn-Jeong Lee ◽  
Hyun-Mi Kang ◽  
...  

2017 ◽  
Vol 22 (19) ◽  
Author(s):  
Wenfei Zhu ◽  
Jianfang Zhou ◽  
Zi Li ◽  
Lei Yang ◽  
Xiyan Li ◽  
...  

With no or low virulence in poultry, avian influenza A(H7N9) virus has caused severe infections in humans. In the current fifth epidemic wave, a highly pathogenic avian influenza (HPAI) H7N9 virus emerged. The insertion of four amino acids (KRTA) at the haemagglutinin (HA) cleavage site enabled trypsin-independent infectivity of this virus. Although maintaining dual receptor-binding preference, its HA antigenicity was distinct from low-pathogenic avian influenza A(H7N9). The neuraminidase substitution R292K conferred a multidrug resistance phenotype.


2015 ◽  
Vol 21 (12) ◽  
pp. 2135-2140 ◽  
Author(s):  
Carmen S. Arriola ◽  
Deborah I. Nelson ◽  
Thomas J. Deliberto ◽  
Lenee Blanton ◽  
Krista Kniss ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document